SICILIANO, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 531
EU - Europa 284
AS - Asia 137
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 957
Nazione #
US - Stati Uniti d'America 523
IE - Irlanda 168
CN - Cina 124
FI - Finlandia 32
DE - Germania 28
IT - Italia 23
CZ - Repubblica Ceca 12
BE - Belgio 9
CA - Canada 8
SG - Singapore 6
SE - Svezia 5
JP - Giappone 4
EG - Egitto 2
IL - Israele 2
UA - Ucraina 2
AL - Albania 1
EU - Europa 1
FR - Francia 1
GB - Regno Unito 1
IR - Iran 1
MU - Mauritius 1
PE - Perù 1
RO - Romania 1
RU - Federazione Russa 1
Totale 957
Città #
Chandler 194
Dublin 168
Beijing 32
Helsinki 32
Boardman 27
Princeton 26
Lawrence 25
Shanghai 25
Medford 24
Ashburn 21
Nanjing 20
Wilmington 16
Brno 12
Pavia 12
Nanchang 11
Brussels 9
Hebei 8
Toronto 8
Munich 7
New York 7
Changsha 6
Hangzhou 6
Jacksonville 6
Fairfield 5
Tianjin 5
Cagliari 4
Redwood City 4
Tokyo 4
Alexandria 3
Berlin 3
Brescia 3
Des Moines 3
Andover 2
Dallas 2
Houston 2
Jiaxing 2
Laurel 2
Seattle 2
Singapore 2
Washington 2
Cairate 1
Clearwater 1
Fuzhou 1
Guangzhou 1
Gunzenhausen 1
Haifa 1
Jerusalem 1
Leawood 1
Lima 1
Littleton 1
London 1
Los Angeles 1
Melegnano 1
Ningbo 1
Rome 1
Timisoara 1
Tirana 1
Totale 769
Nome #
Increase in transporter MATE-1 expression induced by obeticholic acid correlates with higher biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 57
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress 57
Liver graft susceptibility during static cold storage and dynamic machine perfusion: DCD versus fatty livers 56
Comparison between Lipofectamine RNAiMAX and GenMute transfection agents in two cellular models of human hepatoma 54
The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury 48
Oxygen tension-independent protection against hypoxic cell killing in rat liver by low sodium 47
Selective blockade of the metabotropic glutamate receptor mGluR5 protects mouse livers in in vitro and ex vivo models of ischemia reperfusion injury 47
Fatty acid desaturase involvement in non-alcoholic fatty liver disease rat models: Oxidative stress versus metalloproteinases 44
Isolation of rat hepatocytes for pharmacological studies on metabotropic glutamate receptor (mGluR) subtype 5: a comparison between collagenase I versus collagenase IV. 44
Localization and role of metabotropic glutamate receptors subtype 5 in the gastrointestinal tract 43
Serum and hepatic autofluorescence as a real-time diagnostic tool for early cholestasis assessment 43
Fatty liver susceptibility to preservation injury using static cold storage versus dynamic machine perfusion 41
Alterations in stearoyl-CoA-desaturase index and metalloproteinase activity in nutritional versus genetic rat models of NAFLD 39
SAT-389-Obeticholic acid reduces matrix metalloproteinases activity via iNOS modulation in hepatic ischemia/reperfusion injury 38
The FXR agonist obeticholic acid decreases matrix metalloproteinase activity via RECK and TIMP modulation in hepatic ischemia/reperfusion injury 38
The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an in vitro model of benign steatosis 35
Ruolo degli acidi grassi e dello stress ossidativo nella steatosi epatica non alcolica: identificazione di nuovi target molecolari 32
Cold ischemic injury is reduced by the mGluR5 negative allosteric modulator MPEP in rat livers from cardiac death donors 32
INOS-mediated decrease of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 32
Negative allosteric modulators of metabotropic glutamate receptor subtype 5 protect against hepatic ischemia/reperfusion injury 31
Hepatic ischemic injury decreases using negative allosteric modulators of metabotropic glutamate receptor subtype 5 30
RECK- and TIMP-mediated downregulation of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 29
Upregulation of MATE-1 transporter by obeticholic acid correlates with increased biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 29
Lobe-specific oxidative stress and matrix metalloproteinase activation in two animal models of non-alcoholic fatty liver disease (NAFLD) 28
Machine perfusion at 20°C prevents ischemic injury and reduces hypoxia-inducible factor-1α expression during rat liver preservation 25
Totale 999
Categoria #
all - tutte 5.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.250


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202037 0 0 0 0 0 0 1 1 0 12 21 2
2020/202127 0 1 0 0 0 8 8 7 2 1 0 0
2021/2022115 0 0 0 1 0 1 0 6 3 2 39 63
2022/2023500 68 50 2 53 25 53 0 22 198 5 15 9
2023/2024145 33 14 10 5 14 19 9 14 0 6 7 14
2024/202564 7 29 14 10 4 0 0 0 0 0 0 0
Totale 999